NCT06353360 2024-08-09TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma.Jiangsu Healthy Life Innovation Medical Technology Co., LtdPhase 2 Recruiting30 enrolled